Historical Valuation
Procept Biorobotics Corp (PRCT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.35 is considered Undervalued compared with the five-year average of -27.71. The fair price of Procept Biorobotics Corp (PRCT) is between 44.08 to 138.32 according to relative valuation methord. Compared to the current price of 32.83 USD , Procept Biorobotics Corp is Undervalued By 25.53%.
Relative Value
Fair Zone
44.08-138.32
Current Price：32.83
25.53%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Procept Biorobotics Corp (PRCT) has a current Price-to-Book (P/B) ratio of 4.52. Compared to its 3-year average P/B ratio of 9.78 , the current P/B ratio is approximately -53.77% higher. Relative to its 5-year average P/B ratio of 8.68, the current P/B ratio is about -47.91% higher. Procept Biorobotics Corp (PRCT) has a Forward Free Cash Flow (FCF) yield of approximately -4.64%. Compared to its 3-year average FCF yield of -4.66%, the current FCF yield is approximately -0.51% lower. Relative to its 5-year average FCF yield of -4.50% , the current FCF yield is about 3.18% lower.
P/B
Median3y
9.78
Median5y
8.68
FCF Yield
Median3y
-4.66
Median5y
-4.50
Competitors Valuation Multiple
AI Analysis for PRCT
The average P/S ratio for PRCT competitors is 2.96, providing a benchmark for relative valuation. Procept Biorobotics Corp Corp (PRCT.O) exhibits a P/S ratio of 4.35, which is 46.63% above the industry average. Given its robust revenue growth of 42.76%, this premium appears sustainable.
Performance Decomposition
AI Analysis for PRCT
1Y
3Y
5Y
Market capitalization of PRCT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PRCT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PRCT currently overvalued or undervalued?
Procept Biorobotics Corp (PRCT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.35 is considered Undervalued compared with the five-year average of -27.71. The fair price of Procept Biorobotics Corp (PRCT) is between 44.08 to 138.32 according to relative valuation methord. Compared to the current price of 32.83 USD , Procept Biorobotics Corp is Undervalued By 25.53% .
What is Procept Biorobotics Corp (PRCT) fair value?
PRCT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Procept Biorobotics Corp (PRCT) is between 44.08 to 138.32 according to relative valuation methord.
How does PRCT's valuation metrics compare to the industry average?
The average P/S ratio for PRCT's competitors is 2.96, providing a benchmark for relative valuation. Procept Biorobotics Corp Corp (PRCT) exhibits a P/S ratio of 4.35, which is 46.63% above the industry average. Given its robust revenue growth of 42.76%, this premium appears sustainable.
What is the current P/B ratio for Procept Biorobotics Corp (PRCT) as of Jan 10 2026?
As of Jan 10 2026, Procept Biorobotics Corp (PRCT) has a P/B ratio of 4.52. This indicates that the market values PRCT at 4.52 times its book value.
What is the current FCF Yield for Procept Biorobotics Corp (PRCT) as of Jan 10 2026?
As of Jan 10 2026, Procept Biorobotics Corp (PRCT) has a FCF Yield of -4.64%. This means that for every dollar of Procept Biorobotics Corp’s market capitalization, the company generates -4.64 cents in free cash flow.
What is the current Forward P/E ratio for Procept Biorobotics Corp (PRCT) as of Jan 10 2026?
As of Jan 10 2026, Procept Biorobotics Corp (PRCT) has a Forward P/E ratio of -25.92. This means the market is willing to pay $-25.92 for every dollar of Procept Biorobotics Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Procept Biorobotics Corp (PRCT) as of Jan 10 2026?
As of Jan 10 2026, Procept Biorobotics Corp (PRCT) has a Forward P/S ratio of 4.35. This means the market is valuing PRCT at $4.35 for every dollar of expected revenue over the next 12 months.